Given the success of ICIs in other forms of cancer and considering the several instances of PD-L1 positivity in GBM reported in the literature, several studies have investigated the use of ICIs in both primary and recurrent GBM, Table 1 [13,14,15,16]. Here, CD274 is linked to glioblastoma.